VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GLGlobe Life Inc.
$179.31$13.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksGLCash Flow

Globe Life Inc. (GL) Cash Flow Statement

30Y historyFree accessUpdated daily

Operating cash flow remains robust with an OCF/NI ratio peaking at 1.70 in 2025Q1, though significant quarterly fluctuations in net income suggest non-cash accounting impacts on reported profitability.

GL Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations1.39B1.4B1.4B1.48B1.42B1.44B1.48B1.36B1.28B1.43B1.4B1.12B864.71M1.12B942.84M859.46M1.03B976.11M730.61M850M865.59M857.46M767.1M740.47M650.81M662.41M532.77M511.61M397.65M488.83M422.4M
Operating CF Growth %-26.33%-0.43%-5.4%4.24%-1.08%-2.62%8.25%6.75%-10.6%2.17%24.88%29.53%-22.74%18.71%9.7%-16.44%5.38%33.6%-14.05%-1.8%0.95%11.78%3.6%13.78%-1.75%24.33%4.14%28.66%-18.65%15.73%32.18%
Operating CF / Revenue %22.8%23.28%24.27%27.21%27.21%28.07%31.16%30.12%29.61%34.39%35.55%29.74%23.88%32.03%26.27%25.45%30.54%31.34%22.86%24.38%25.3%27.43%24.97%25.26%23.57%24.47%21.15%22.97%18.43%23.6%19.15%
Net Income1.18B1.16B1.07B970.75M894.39M744.96M731.77M760.88M701.51M1.46B539.59M516.29M528.07M528.47M529.32M497.62M522.29M386.05M452.26M527.53M518.63M495.39M475.7M430.14M383.43M356.51M372.12M273.96M244.44M337.74M311.37M
Depreciation & Amortization00000000000000000000004.8M4.81M302.73M5.82M6.86M8.84M7.93M9.33M9.06M
Stock-Based Compensation0000000000000000000000000000000
Deferred Taxes0000000000000000000000074.95M38.7M82.14M00000
Other Non-Cash Items208.24M-367.49M-401.43M-303.35M-311.74M-289.81M-154.69M-136.67M-110.46M-816.33M168.53M-159.6M-325.88M-128.86M-133.48M-103.15M-138.46M15.69M24.59M-2.73M11.26M7.11M286.6M718.05M403.42M336.64M-152.76M159.95M301.88M264.98M196.42M
Working Capital Changes0602.64M733.1M815.01M839.54M982.53M899.35M739.66M686.59M787.12M690.59M763.35M662.52M719.67M547M464.99M644.76M574.37M253.76M325.2M335.7M354.95M0-487.49M-477.46M-118.7M306.56M68.87M-156.6M-123.22M-94.45M
Cash from Investing-684.93M-643.62M-641.52M-926.15M-943.01M-913.37M-1.18B-809.31M-896.22M-926.82M-1.06B-633.35M-350.16M-614.38M-698.04M-312.13M-557.64M-937.1M-432.25M-502.6M-520.6M-498.96M-499.2M-599.68M-468.55M-442.75M-243.71M-387.18M-555.34M-468.28M-182.91M
Capital Expenditures-155.65M-142.48M-71.05M-49.55M-27.93M-38.24M-41.76M-42.2M-45.09M-20.29M-25.16M-36.96M-19.37M-11.17M-4.67M-5.39M-9.18M-6.5M-9.8M-24.16M-7.67M-3.02M-4M-3.61M-2.44M-3.69M-6.51M-8.49M-6.17M-9.42M-15.41M
Acquisitions000000000090K08.75M570K-186.37M24.68M342.97M0786K-41.03M6.31M0400K3.37M197K000143.44M1.69M15.5M
Purchase of Investments-1.52B-1.63B-2.09B-1.96B-1.85B-1.32B-1.64B-1.73B-1.29B-1.47B-1.62B-1.2B-784.3M-1.22B-1.6B-1.21B-1.99B-2.59B-1.16B-2.1B-1.39B-1.01B-1.26B-1.41B-1.26B-1.6B-1.14B-2.2B-2.01B-1.78B-1.15B
Sale/Maturity of Investments1.1B1.13B1.52B1.08B935.54M502.63M511.99M958.47M439.99M559.62M578M606.69M444.75M660.65M1.09B877.76M1.1B1.67B721.17M1.73B817.56M557.51M737.4M1.44B1.32B1.16B899.04M1.82B1.3B1.31B871.05M
Other Investing-101.53M096K00-56.7M-7.05M32K1.99M18K000-43.99M3.65M2.66M-754K-13.83M17.93M-73.27M54.49M-40.81M29.6M-620.8M-527.65M1.16M1.27M8.09M16.46M16.48M96.02M
Cash from Financing-673.22M-768.05M-715.84M-541.49M-492.45M-523.6M-274.06M-590.51M-391.52M-453.98M-319.79M-525.71M-499.96M-535.92M-269.11M-824.49M-329.62M148.44M-261.26M-346.75M-347.57M-349.85M-269.9M-135.26M-178.79M-251.04M-268.42M-114.92M151.52M-13.06M-234.38M
Dividends Paid-87.28M-86.07M-85.48M-84.12M-80.55M-80.04M-78.19M-74.19M-71.42M-68.83M-66.93M-66.9M-65.01M-60.91M-55.53M-49.13M-50.06M-46.62M-48.8M-49.58M-48.09M-46.35M-48.8M-43.85M-43.5M-45.19M-46.42M-48.17M-90.78M-81M-82.89M
Share Repurchases-856.9M-880.98M-1B-511.1M-454.64M-541.43M-443.87M-459.57M-421.75M-412.99M-404.78M-418.53M-449.31M-482.26M-570.16M-972.56M-246.01M-47.56M-455.74M-451.79M-344.86M-554.95M-285.23M-225.27M-182.19M-503.08M-147.01M-221.88M-161.13M-182.9M-107M
Stock Issued104.45M164.45M51.79M114.08M106.59M69.83M48.09M83.16M36.09M61.22M61.33M35.96M56.29M97.82M181.02M162.61M37.86M4.43M25.47M42.64M21.45M217.26M000135M9.89M37.16M520.1M94M10.14M
Debt Issuance (Net)-2M-1000K1000K1000K1000K1000K1000K-1000K1000K1000K1000K1000K1000K-1000K1000K1000K-1000K1000K1000K1000K-1000K1000K-1000K-1000K-1000K1000K-1000K1000K-1000K1000K-1000K
Other Financing186.36M145.29M-301.61M-96.94M-112.79M-64.24M-72.93M-121.43M-126.99M-90.93M-71.99M-78.22M-51.27M-493K31.13M8.62M-28.07M112.26M115.63M79.66M28.73M2.88M50.1M98.5M44.43M-26.64M10.52M66.95M49.64M78.74M94.51M
Net Change in Cash22.94M-20.62M62.17M10.6M396K-2.68M18.91M-45.09M2.46M42.4M14.78M-4.64M29.08M-24.77M-22.4M-281.57M133.76M185.52M26.3M3.38M-2.58M8.65M-2M5.53M3.47M-31.38M20.65M9.52M-6.17M7.49M5.11M
Exchange Rate Effect-4.36M-5.34M17.08M-4.19M13.67M-3.39M-1.73M-9.15M12.56M-5.85M-1.7M34.37M14.49M6.25M1.91M-4.41M-7.57M-1.93M-10.8M2.73M00000000000
Cash at Beginning144.7M165.32M103.16M92.56M92.16M94.85M75.93M121.03M118.56M76.16M61.38M66.02M36.94M61.71M84.11M365.68M231.92M46.4M20.1M16.72M19.3M10.65M12.7M7.18M3.71M35.09M14.44M4.92M11.09M18.27M13.16M
Cash at End255.21M144.7M165.32M103.16M92.56M92.16M94.85M75.93M121.03M118.56M76.16M61.38M66.02M36.94M61.71M84.11M365.68M231.92M46.4M20.1M16.72M19.3M10.7M12.71M7.18M3.71M35.09M14.44M4.92M25.77M18.27M
Free Cash Flow1.23B1.25B1.33B1.43B1.39B1.4B1.43B1.32B1.23B1.41B1.37B1.08B845.34M1.11B938.17M854.08M1.02B969.61M720.81M825.84M857.92M854.44M763.1M736.86M648.37M658.72M526.27M503.12M391.48M479.41M406.98M
FCF Growth %-12.77%-5.82%-7.08%2.77%-0.37%-2.46%8.55%7.23%-12.51%2.56%26.82%28.13%-23.71%18.11%9.85%-16.22%5.14%34.52%-12.72%-3.74%0.41%11.97%3.56%13.65%-1.57%25.17%4.6%28.52%-18.34%17.8%30%
FCF Margin %20.23%20.9%23.04%26.3%26.68%27.33%30.28%29.19%28.57%33.9%34.91%28.76%23.35%31.71%26.14%25.29%30.27%31.13%22.55%23.69%25.08%27.33%24.84%25.14%23.48%24.33%20.89%22.59%18.14%23.15%18.45%
FCF per Share15.4115.5115.7114.8714.0913.5613.3811.8710.6911.8411.228.546.377.946.395.185.525.193.623.833.773.593.032.842.392.351.821.721.281.531.26

Key Metrics

Growth RegimeStable
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Captive agency distribution volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Consistent Underwriting Cash Flow Generation

According to the provided quarterly data, Globe Life consistently generates positive operating cash flow, with the OCF/NI ratio averaging well above 1.0, peaking at 1.70 in 2025Q1, which highlights the company's ability to convert accounting earnings into tangible cash through its core insurance operations.

The persistent gap between net income and operating cash flow suggests that non-cash accruals and reserve adjustments play a significant role in the company's reported earnings. Investors should monitor whether this cash generation remains resilient if mortality trends deviate from current actuarial expectations.

Active Investment Portfolio Liquidity Management

As reported in financial statements, Globe Life maintains an active investment strategy, frequently cycling capital through purchases and sales, such as the $842.4 million in investment purchases during 2024Q1, indicating a proactive approach to managing yield in a fluctuating interest rate environment.

The frequent turnover in the investment portfolio suggests that management is aggressively seeking to optimize the duration and yield of its assets to match long-term policy liabilities. This activity appears to be a primary lever for maintaining investment income stability despite the inherent volatility in market valuations.

Aggressive Capital Return Strategy Sustainability

Based on the company's reported figures, Globe Life has demonstrated a significant commitment to shareholder returns, with buybacks reaching $591.1 million in 2024Q3, a level that warrants investigation into the long-term sustainability of such capital deployment relative to the company's underlying cash generation capacity.

The high volume of share repurchases relative to quarterly net income suggests that management prioritizes returning capital to shareholders over building a massive cash buffer. This strategy may leave the company with less flexibility should it face unexpected spikes in claims or a sudden need for increased statutory capital.

Divergence Between Statutory Earnings and Cash

Data from the last ten quarters indicates that Globe Life's net income often fluctuates independently of operating cash flow, as seen in 2025Q3 when net income hit $387.8 million while operating cash flow was only $306.0 million, suggesting significant non-cash accounting impacts on reported profitability.

This divergence implies that reported earnings may be sensitive to changes in reserve assumptions or deferred acquisition cost amortization. Analysts should interpret these earnings figures with caution, as they may not always reflect the immediate cash-generating power of the underlying insurance business.

GL — Frequently Asked Questions

Quick answers to the most common questions about buying GL stock.

How much cash does Globe Life Inc. (GL) generate from operations?

Globe Life Inc. (GL) generated $1.40B in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Globe Life Inc.'s free cash flow?

Globe Life Inc. (GL) generated $1.25B in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Globe Life Inc.'s capital expenditure (CapEx)?

Globe Life Inc. (GL) spent $142.5M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Globe Life Inc. distribute cash to shareholders?

In 2025, Globe Life Inc. (GL) returned $86.1M to shareholders via cash dividends and spent $881.0M on share repurchases. This shows the company's commitment to returning capital to its equity investors.